Interleukin 10 production by human melanoma

Clinical Cancer Research

Volumn 2, Issue 8, 1996, Pages 1383-1390

  Sato, Takami ^a,b   McCue, Peter ^b   Masuoka, Kazuhiro ^b   Salwen, Sarah ^b   Lattime, Edmund C ^b   Mastrangelo, Michael J ^b   Berd, David ^b  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10;

ANTIBODY BLOOD LEVEL; ANTIGEN SPECIFICITY; ARTICLE; CELL PROLIFERATION; CELLULAR IMMUNITY; DELAYED HYPERSENSITIVITY; FEEDBACK SYSTEM; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MELANOMA; PRIORITY JOURNAL;

CRYOPRESERVATION; FEMALE; HUMANS; INTERLEUKIN-10; MALE; MELANOMA; RNA, MESSENGER; TUMOR CELLS, CULTURED;

EID: 0029774810     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Howard, M., and O'Garra, A. Biological properties of interleukin 10, Immunol. Today, 13: 198-200, 1992.
2. Enk, C. D. Sredni, D., Blauvelt, A., and Katz, S. I. Induction of IL-10 gene expression in human keratinocytes by UVB exposure in vivo and in vitro. J. Immunol., 154: 4851-4856, 1995.
3. Ding, L., and Shevach, E M. IL-10 inhibits mitogen-induced T cell proliferation by selectively inhibiting macrophage costimulatory function. J. Immunol., 148: 3133-3139, 1992.
4. Powrie, F., Menon, S., and Coffman, R. L. Interleukin-4 and interleukin-10 synergize to inhibit cell-mediated immunity in vivo. Eur. J. Immunol., 23: 2223-2229, 1993.
5. Schwarz, A., Grabbe, S., Riemann, H., Aragane, Y., Simon, M., Manon, S., Andrade, S., Luger, T. A., Zlotnik, A., and Schwarz, T. In vivo effects of interleukin-10 on contact hypersensitivity and delayed-type hypersensitivity reactions. J. Invest. Dermatol., 103: 211-216, 1994.
6. Enk, A. H., Saloga. J., Becker, D., Mohamadzadeh, M., and Knop, J. Induction of hapten-specific tolerance by interleukin 10 in vivo. J. Exp. Med., 179: 1397-1402, 1994.
7. Kuhn, R., Lohler, J., Rennick, D., Rajewsky, K., and Muller, W. Interleukin-10-deficient mice develop chronic enterocolitts. Cell, 75: 263-274, 1993.
8. Tonnetti, L., Spaccapelo, R., Cenci, E., Mencacci, A., Puccetti, P., Coffman, R. L., Bistoni, F., and Romani, L. Interleukin-4 and -10 exacerbate candidiasis in mice. Eur. J. Immunol., 25: 1559-1565, 1995.
9. Arai, T., Hiromatsu, K., Nishimura, H., Kimura, Y., Kobayashi, N., Ishida, H., Nimura, Y., and Yoshikai, Y. Effects of in vivo administration of anti-IL-10 monoclonal antibody on the host defence mechanism against murine Salmonella infection. Immunology, 85: 381-388, 1995.
10. Chemoff, A. E., Granowitz, E. V., Shapiro, L., Vannier, E., Lonnemann, G., Angel, J. B., Kennedy, J. S., Rabson, A. R., Wolff, S. M., and Dinarello, C. A. A randomized, controlled trial of IL-10 in humans: inhibition of inflammatory cytokine production and immune responses. J. Immunol., 154: 5492-5499, 1995.
11. Chen, Q., Daniel, V., Maher, D. W., and Hersey, P. Production of IL-10 by melanoma cells. examination of its role in immunosuppression mediated by melanoma. Int. J. Cancer, 56: 755-760, 1994.
12. Lattime, E. C., Mastrangelo, M. J., and Berd, D. Human metastatic melanoma lesions and cell lines express mRNA for IL-10. Proc. Am. Assoc. Cancer Res., 35: 489, 1994.
13. Lattime, E. C., Mastrangelo, M. J., Bagasra, O., Li, W., and Berd, D. Expression of cytokine mRNA in human melanoma tissues. Cancer Immunol. Immunother., 41: 151-156, 1995
14. Krüger-Krasagakes, S., Krasagakis, K., Garbe, C., Schmitt, E., Hüls, C., Blankenstein, T., and Diamantstein, T. Expression of interleukin 10 in human melanoma. Br. J. Cancer, 70: 1182-1185, 1994.
15. Berd, D., Murphy, G., Maguire, H. C., Jr., and Mastrangelo, M J. Immunization with haptenized, autologous tumor cells induces inflammation of human melanoma metastases. Cancer Res., 51: 2731-2734, 1991.
16. Berd, D , Maguire, H. C., Jr., and Mastrangelo, M. J. Treatment of human melanoma with a hapten-modified autologous vaccine. Ann. NY Acad. Sci., 690: 147-152, 1993.
17. Berd, D., Maguire, H. C , Jr., and Mastrangelo, M. J Induction of cell-mediated immunity to autologous melanoma cells and regression of metastases after treatment with a melanoma cell vaccine preceded by cyclophosphamide. Cancer Res., 46: 2572-2577, 1986.
18. Morgan, A. C., Jr., Galloway, D. R., and Reisfeld, R. A. Production and characterization of monoclonal antibody to a melanoma specific glycoprotein. Hybridoma, 1: 27-36, 1981.
19. Lewis, R. E., Buchsbaum, M., Whitaker, D., and Murphy, G. F. Intercellular adhesion molecule expression in the evolving human cutaneous delayed hypersensitivity reaction. J. Invest. Dermatol., 93: 672-677, 1989.
20. Gastl, G. A., Abrams, J. S., Nanus, D. M., Oosterkamp, R., Silver, J., Liu, F., Chen, M., Albino, A. P., and Bander, N. H. Interleukin-10 production by human carcinoma cell lines and its relationship to interleukin-6 expression. Int. J. Cancer, 55: 96-101, 1993.
21. Pisa, P., Halapi, E., Pisa, E. K., Gerdin, E., Hising, C., Bucht, A , Gerdin, B., and Kiessling, R. Selective expression of interleukin 10, interferon γ, and granulocyte-macrophage colony-stimulating factor in ovarian cancer biopsies. Proc. Natl. Acad. Sci. USA, 89: 7708-7712, 1992.
22. Gastl, G., Liu, F., Finstad, C. L., Nanus, D. M., and Bander, N. H. Local expression of immune response genes in human renal cancer. Proc. Am. Assoc. Cancer Res., 33: 353, 1992.
23. Huettner, C., Paulus, W , and Roggendorf, W. Messenger RNA expression of the immunosuppressive cytokine IL-10 in human gliomas. Am. J. Pathol., 146: 317-322, 1995.
24. Yamamura, M., Modlin, R. L., Ohmen, J. D., and Moy, R. L. Local expression of antiinflammatory cytokines in cancer. J. Clin. Invest., 91: 1005-1010, 1993.
25. Huang, M., Wang, J. Y., Lee, P., Sharma, S., Mao, J. T., Meissner, H., Uyemura, K., Modlin, R., Wollman, J., and Dubinett, S. M. Human non-small cell lung cancer cells express a type 2 cytokine pattern. Cancer Res., 55: 3847-3853, 1995.
26. Lattime, E. C., McCue, P. A., Keeley, F. X., Li, W., and Gomella, L. G. Expression of IL-10 mRNA in biopsies of superficial and invasive transitional cell carcinoma of the human bladder. Proc. Am. Assoc. Cancer Res., 36: 462, 1995.
27. Emilie, D., Touitou, R., Raphael, M., Peuchmaur, M., Devergnee, O., Rea, D., Coumbraras, J., Crevon, M-C., Edelman, L., Joab, I., and Galanaud, P. In vivo production of interleukin-10 by malignant cells in AIDS lymphomas. Eur. J. Immunol., 22: 2937-2942, 1992.
28. Smith, D. R., Kunkel, S L., Burdick, M. D., Wilke, C. A., Orringer, M B., Whyte, R. I., and Stricter, R. M. Production of interleukin-10 by human bronchogenic carcinoma. Am. J. Pathol., 145: 18-25, 1994.
29. Schadendorf, D., Moller, A., Algermissen, B., Worm, M., Sticherling, M., and Czametzki, B. M. IL-8 produced by human malignant melanoma cells in vitro is an essential autocrine growth factor [published erratum appears in J. Immunol. 153: 3360, 1994]. J. Immunol., 757: 2667-2675, 1993.
30. Scheibenbogen, C., Mohler, T., Haefele, J., Hunstein, W., and Keilholz, U. Serum interleukin-8 (IL-8) is elevated in patients with metastatic melanoma and correlates with tumour load. Melanoma Res., 5: 179-181, 1995.
31. Gorelik, L., Prokhorova, A., and Mokyr, M. B Low-dose melphalan-induced shift in the production of a Th2-type cytokine to a Th1-type cytokine in mice bearing a large MOPC-315 tumor. Cancer Immunol. Immunother., 39: 117-126, 1994.
32. Wang, L., Goillot, E., and Tepper, R. I. IL-10 inhibits alloreactive cytotoxic T lymphocyte generation in vivo. Cell. Immunol., 159: 152-169, 1994.
33. Suzuki, T., Tahara, H., Narula, S., Moore, K. W., Robbins, P. D., and Lotze, M. T. Viral interleukin 10 (IL-10), the human herpes virus 4 cellular IL-10 homologue, induces local anergy to allogeneic and syngeneic tumors. J. Exp. Med., 182: 477-486, 1995.
34. Berd, D., Maguire, H. C., Jr., Mastrangelo, M. J., and Murphy, G. F. Activation markers on T cells infiltrating melanoma metastases after therapy with dinitrophenyl-conjugated vaccine. Cancer Immunol. Immunother., 39: 141-147, 1994.
35. + T lymphocyte migration. J. Immunol., 151: 4545-4551, 1993.
36. Allione, A., Consalvo, M., Nanni, P., Lollini, P. L., Cavallo, F., Giovarelli, M., Forni, M., Gulino, A., Colombo, M. P., Dellabona, P., Hock, H., Blankenstein, T., Rosenthal, F. M , Gansbacher, B., Bosco, M. C., Musso, T., Gusella, L., and Forni, G. Immunizing and curative potential of replicating and nonreplicating murine mammary adenocarcinoma cells engineered with interleukin (IL)-2.IL-4, IL-6, IL-7, IL-10, tumor necrosis factor α, granulocyte-macrophage colony-stimulating factor, and γ-interferon gene or admixed with conventional adjuvants. Cancer Res., 54: 6022-6026, 1994.
37. Dummer, W., Backer, J. C., Schwaaf, A., Leverkus, M., Moll, T., and Brocker, E. B. Elevated serum levels of inteileukin-10 in patients with metastatic malignant melanoma. Melanoma Res., 5: 67-68, 1995.
38. Derkx, B., Marchant, A., Goldman, M., Bijlmer, R., and Van Deventer, S. High levels of interleukin-10 during the initial phase of fulminant meningococcal septic shock. J. Infect. Dis., 171: 229-232, 1995.
39. Peyron, F., Burdin, N., Ringwald, P., Vuillez, J. P., Rousset, F., and Banchereau, J. High levels of circulating IL-10 in human malaria. Clin. Exp. Immunol., 95: 300-303, 1994.
40. Wenisch, C., Parschalk, B., Narzt, E., Looareesuwan, S., and Graninger, W. Elevated serum levels of IL-10 and IFN-γ in patients with acute Plasmodium falciparum malaria. Clin. Immunol. Immunopathol., 74: 115-117, 1995.
41. Merville, P., Rousset, F., Banchereau, J., Klein, B., and Bataille, R. Serum interleukin 10 in early stage multiple myeloma. Lancet, 340: 1544-1545, 1992.
42. Blay, J-Y., Burdin, N., Rousset F., Lenoir, G., Biron, P., Philip, T., Banchereau, J., and Favrot, M. C. Serum interleukin-10 in non-Hodgkin's lymphoma: a prognostic factor. Blood, 82: 2169-2174, 1993.